ZA9510708B - Spray dried erythropoietin - Google Patents
Spray dried erythropoietinInfo
- Publication number
- ZA9510708B ZA9510708B ZA9510708A ZA9510708A ZA9510708B ZA 9510708 B ZA9510708 B ZA 9510708B ZA 9510708 A ZA9510708 A ZA 9510708A ZA 9510708 A ZA9510708 A ZA 9510708A ZA 9510708 B ZA9510708 B ZA 9510708B
- Authority
- ZA
- South Africa
- Prior art keywords
- spray dried
- erythropoietin
- dried erythropoietin
- rhepo
- provides
- Prior art date
Links
- 239000007921 spray Substances 0.000 title abstract 2
- 102000003951 Erythropoietin Human genes 0.000 title 1
- 108090000394 Erythropoietin Proteins 0.000 title 1
- 229940105423 erythropoietin Drugs 0.000 title 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35794794A | 1994-12-16 | 1994-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9510708B true ZA9510708B (en) | 1997-06-17 |
Family
ID=23407689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9510708A ZA9510708B (en) | 1994-12-16 | 1995-12-15 | Spray dried erythropoietin |
Country Status (19)
Country | Link |
---|---|
US (2) | US6001800A (ja) |
EP (1) | EP0805822B2 (ja) |
JP (1) | JP4039686B2 (ja) |
CN (1) | CN1117762C (ja) |
AT (1) | ATE265468T1 (ja) |
AU (1) | AU697287B2 (ja) |
CA (1) | CA2207615C (ja) |
DE (1) | DE69532970T3 (ja) |
DK (1) | DK0805822T4 (ja) |
ES (1) | ES2219672T5 (ja) |
FI (1) | FI119723B (ja) |
HU (1) | HU222370B1 (ja) |
IL (1) | IL116085A (ja) |
NO (1) | NO319895B1 (ja) |
NZ (1) | NZ298981A (ja) |
PT (1) | PT805822E (ja) |
TW (1) | TW425287B (ja) |
WO (1) | WO1996018647A1 (ja) |
ZA (1) | ZA9510708B (ja) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19539574A1 (de) * | 1995-10-25 | 1997-04-30 | Boehringer Mannheim Gmbh | Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren |
US6151332A (en) | 1997-06-20 | 2000-11-21 | Tantivy Communications, Inc. | Protocol conversion and bandwidth reduction technique providing multiple nB+D ISDN basic rate interface links over a wireless code division multiple access communication system |
US6081536A (en) | 1997-06-20 | 2000-06-27 | Tantivy Communications, Inc. | Dynamic bandwidth allocation to transmit a wireless protocol across a code division multiple access (CDMA) radio link |
US6542481B2 (en) | 1998-06-01 | 2003-04-01 | Tantivy Communications, Inc. | Dynamic bandwidth allocation for multiple access communication using session queues |
EP0913177A1 (de) * | 1997-11-03 | 1999-05-06 | Roche Diagnostics GmbH | Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung |
US7496072B2 (en) | 1997-12-17 | 2009-02-24 | Interdigital Technology Corporation | System and method for controlling signal strength over a reverse link of a CDMA wireless communication system |
US7936728B2 (en) | 1997-12-17 | 2011-05-03 | Tantivy Communications, Inc. | System and method for maintaining timing of synchronization messages over a reverse link of a CDMA wireless communication system |
US7394791B2 (en) | 1997-12-17 | 2008-07-01 | Interdigital Technology Corporation | Multi-detection of heartbeat to reduce error probability |
US6222832B1 (en) | 1998-06-01 | 2001-04-24 | Tantivy Communications, Inc. | Fast Acquisition of traffic channels for a highly variable data rate reverse link of a CDMA wireless communication system |
US9525923B2 (en) | 1997-12-17 | 2016-12-20 | Intel Corporation | Multi-detection of heartbeat to reduce error probability |
US7773566B2 (en) | 1998-06-01 | 2010-08-10 | Tantivy Communications, Inc. | System and method for maintaining timing of synchronization messages over a reverse link of a CDMA wireless communication system |
US8134980B2 (en) | 1998-06-01 | 2012-03-13 | Ipr Licensing, Inc. | Transmittal of heartbeat signal at a lower level than heartbeat request |
US6526034B1 (en) | 1999-09-21 | 2003-02-25 | Tantivy Communications, Inc. | Dual mode subscriber unit for short range, high rate and long range, lower rate data communications |
WO2001058044A2 (en) | 2000-02-07 | 2001-08-09 | Tantivy Communications, Inc. | Minimal maintenance link to support synchronization |
US8155096B1 (en) | 2000-12-01 | 2012-04-10 | Ipr Licensing Inc. | Antenna control system and method |
US6954448B2 (en) | 2001-02-01 | 2005-10-11 | Ipr Licensing, Inc. | Alternate channel for carrying selected message types |
US7551663B1 (en) | 2001-02-01 | 2009-06-23 | Ipr Licensing, Inc. | Use of correlation combination to achieve channel detection |
ES2284858T3 (es) * | 2001-02-02 | 2007-11-16 | Ortho-Mcneil Pharmaceutical, Inc. | Tratamiento de disfuncion neurologica que comprende sulfamatos de fructopiranosa y eritropoyetina. |
ES2614202T3 (es) | 2001-06-13 | 2017-05-30 | Intel Corporation | Método y aparato para la transmisión de una señal de latido de corazón a un nivel inferior que la solicitud de latido de corazón |
AU2003263552A1 (en) | 2002-09-09 | 2004-03-29 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
JP2006514954A (ja) * | 2002-12-31 | 2006-05-18 | ネクター セラピューティクス | 抗体含有粒子及び組成物 |
WO2005054301A1 (ja) | 2003-11-14 | 2005-06-16 | Chugai Seiyaku Kabushiki Kaisha | 架橋多糖微粒子およびその製造方法 |
MX2007007590A (es) | 2004-12-22 | 2007-12-10 | Ambrx Inc | Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos. |
ATE542920T1 (de) | 2004-12-22 | 2012-02-15 | Ambrx Inc | Modifiziertes menschliches wachstumshormon |
US20090018029A1 (en) | 2005-11-16 | 2009-01-15 | Ambrx, Inc. | Methods and Compositions Comprising Non-Natural Amino Acids |
AU2007292903B2 (en) | 2006-09-08 | 2012-03-29 | Ambrx, Inc. | Modified human plasma polypeptide or Fc scaffolds and their uses |
WO2008065372A2 (en) | 2006-11-28 | 2008-06-05 | Nautilus Biotech, S.A. | Modified erythropoietin polypeptides and uses thereof for treatment |
KR101476472B1 (ko) | 2007-03-30 | 2015-01-05 | 암브룩스, 인코포레이티드 | 변형된 fgf-21 폴리펩티드 및 그 용도 |
CA2685596A1 (en) | 2007-05-02 | 2008-11-13 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
SG2013054218A (en) * | 2008-01-15 | 2014-10-30 | Abbott Gmbh & Co Kg | Powdered protein compositions and methods of making same |
JP5680534B2 (ja) | 2008-07-23 | 2015-03-04 | イーライ リリー アンド カンパニー | 修飾されているウシg−csfポリペプチドおよびそれらの使用 |
PT104350A (pt) | 2009-01-23 | 2010-07-23 | Hovione Farmaci Ncia S A | Processo de isolamento de tigeciclina |
CN107674121A (zh) | 2009-12-21 | 2018-02-09 | Ambrx 公司 | 经过修饰的牛促生长素多肽和其用途 |
CN104017063A (zh) | 2009-12-21 | 2014-09-03 | Ambrx公司 | 经过修饰的猪促生长素多肽和其用途 |
AR083006A1 (es) | 2010-09-23 | 2013-01-23 | Lilly Co Eli | Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas |
CA2823628A1 (en) | 2011-01-05 | 2012-07-12 | Hospira, Inc. | Spray drying vancomycin |
US9566241B2 (en) | 2012-02-21 | 2017-02-14 | Auburn University | Buprenorphine nanoparticle composition and methods thereof |
CN104043104B (zh) | 2013-03-15 | 2018-07-10 | 浙江创新生物有限公司 | 含盐酸万古霉素的喷雾干粉及其工业化制备方法 |
KR102637699B1 (ko) | 2014-10-24 | 2024-02-19 | 브리스톨-마이어스 스큅 컴퍼니 | 변형된 fgf-21 폴리펩티드 및 그의 용도 |
CN104984323B (zh) * | 2015-06-12 | 2018-05-01 | 北京四环生物制药有限公司 | 注射用重组人促红素冻干粉针剂 |
CN105311624A (zh) * | 2015-11-23 | 2016-02-10 | 哈药集团生物工程有限公司 | 一种含有重组人促红素的药物组合物 |
PL3849614T3 (pl) | 2018-09-11 | 2024-04-22 | Ambrx, Inc. | Koniugaty polipeptydu interleukiny-2 i ich zastosowania |
CN113366015A (zh) | 2018-10-19 | 2021-09-07 | Ambrx公司 | 白细胞介素-10多肽缀合物、其二聚体及其用途 |
EP3923991A1 (en) | 2019-02-12 | 2021-12-22 | Ambrx, Inc. | Compositions containing, methods and uses of antibody-tlr agonist conjugates |
AU2021233909A1 (en) | 2020-03-11 | 2022-09-29 | Ambrx, Inc. | Interleukin-2 polypeptide conjugates and methods of use thereof |
KR20230073200A (ko) | 2020-08-20 | 2023-05-25 | 암브룩스, 인코포레이티드 | 항체-tlr 작용제 접합체, 그 방법 및 용도 |
JP2024512775A (ja) | 2021-04-03 | 2024-03-19 | アンブルックス,インコーポレイテッド | 抗her2抗体薬物コンジュゲート及びその使用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57149228A (en) * | 1981-03-11 | 1982-09-14 | Ajinomoto Co Inc | Novel erythropoietin and its preparation |
JPS6197229A (ja) * | 1984-10-18 | 1986-05-15 | Chugai Pharmaceut Co Ltd | 安定なエリトロポエチン製剤 |
DE3729863A1 (de) * | 1987-09-05 | 1989-03-16 | Boehringer Mannheim Gmbh | Stabilisierte erythropoietin-lyophilisate |
GB9001987D0 (en) * | 1990-01-29 | 1990-03-28 | Janssen Pharmaceutica Nv | Improved cyclodextrin based erythropietin formulation |
US5354934A (en) * | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
-
1995
- 1995-11-21 IL IL11608595A patent/IL116085A/xx not_active IP Right Cessation
- 1995-12-15 HU HU9800996A patent/HU222370B1/hu active IP Right Grant
- 1995-12-15 EP EP95943452A patent/EP0805822B2/en not_active Expired - Lifetime
- 1995-12-15 CA CA2207615A patent/CA2207615C/en not_active Expired - Lifetime
- 1995-12-15 AT AT95943452T patent/ATE265468T1/de active
- 1995-12-15 AU AU44713/96A patent/AU697287B2/en not_active Expired
- 1995-12-15 ES ES95943452T patent/ES2219672T5/es not_active Expired - Lifetime
- 1995-12-15 ZA ZA9510708A patent/ZA9510708B/xx unknown
- 1995-12-15 PT PT95943452T patent/PT805822E/pt unknown
- 1995-12-15 CN CN95197638.9A patent/CN1117762C/zh not_active Expired - Lifetime
- 1995-12-15 DE DE69532970T patent/DE69532970T3/de not_active Expired - Lifetime
- 1995-12-15 NZ NZ298981A patent/NZ298981A/xx not_active IP Right Cessation
- 1995-12-15 DK DK95943452.3T patent/DK0805822T4/da active
- 1995-12-15 JP JP51929496A patent/JP4039686B2/ja not_active Expired - Lifetime
- 1995-12-15 WO PCT/US1995/016416 patent/WO1996018647A1/en active IP Right Grant
-
1996
- 1996-06-06 TW TW085106816A patent/TW425287B/zh not_active IP Right Cessation
- 1996-12-15 US US08/894,023 patent/US6001800A/en not_active Expired - Lifetime
-
1997
- 1997-06-13 NO NO19972725A patent/NO319895B1/no not_active IP Right Cessation
- 1997-06-16 FI FI972557A patent/FI119723B/fi not_active IP Right Cessation
-
1999
- 1999-10-12 US US09/415,726 patent/US6235710B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69532970D1 (en) | Sprühgetrocknetes erythropoietin | |
EP0702040A3 (ja) | ||
HK1010196A1 (en) | Novel 2,3-dioxo-1,2,3,4-tetrahdro-quinoyxalinyl derivatives. | |
HUP0002105A3 (en) | Method for preparing 1,1,1,3,3-pentachlorobutane | |
AU1148099A (en) | Powder varnish composition, method for producing and the use thereof | |
EP1023250A4 (en) | METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE | |
AU4278897A (en) | 10,13,15-Trioxatricyclo(9.2.1.1.9.6)-Pentadecanone derivatives, method for the production thereof and medicaments containing these compounds | |
IL126989A (en) | Process for making 4,6-dihydroxypyrimidine | |
ZA974084B (en) | Novel α-glucuronidases, production hereof and their uses. | |
AU2316897A (en) | Cyclic imido-1,3,5-triazine crosslinking agents | |
GB2289682B (en) | Self-crosslinking composition,a product obtained from the composition,and method for manufacturing the product | |
MX9603516A (es) | Derivados de oxima y su uso como pesticidas. | |
EP0653466A3 (en) | Powder coating. | |
HUP9802316A3 (en) | Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same | |
EP0694538A3 (en) | 2-Benzyloxy-4-phenoxy pyrimidine derivatives, process for their preparation and herbicidal compositions containing them | |
HUT77004A (hu) | Antiaritmiás szerekként felhasználható nitro-benzamidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
AU7570798A (en) | Ionic halomethyl-1,3,5-triazine photoinitiators | |
EP0680790A3 (en) | Powder nozzle. | |
ZA972302B (en) | 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives. | |
AU1568895A (en) | Process for preparing 2,6-dichloropyridine | |
AU4715196A (en) | Desaminononapeptides, process for preparing the same and their use for preparing elcatonin | |
AU7035998A (en) | New thiazoledinediones, method for the production thereof, and medicaments containing the same | |
ZA991215B (en) | Process for the preparation of 1,3-disubstituted 2-nitroguanidines. | |
NO902138D0 (no) | Fremgangsmaate for pulverbelegging. | |
AU5322198A (en) | New phosphonates, process for preparing the same and medicaments |